Xenon Pharmaceuticals Inc. ( XENE) - Key Metrics
XENE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | ? | ? | ? | ? |
| 2025Q1 | $0.10 | -$0.83 | -$0.78 | -$0.78 |
XENE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | -10.15 |
XENE
Price: $53.26
52 week price:
Earnings Per Share: -4.70 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 730900
Ebitda: -8.5 millionMarket Capitalization: 4.2 billion